1Day Sooner
@1daysooner.bsky.social
1Day Sooner leads campaigns in science, policy, and bioethics to stop the world’s most harmful infectious diseases. We advocate for volunteers who participate in high-impact medical studies, including human challenge studies. www.1daysooner.org
Adverse event reporting across controlled human infection studies is inconsistent, making data aggregation and reuse difficult. Our new paper evaluates the use of ClinicalTrials.gov for CHIS data reporting and compares itwith the same data in corresponding published articles. bit.ly/41boTyz
February 12, 2025 at 4:01 PM
Adverse event reporting across controlled human infection studies is inconsistent, making data aggregation and reuse difficult. Our new paper evaluates the use of ClinicalTrials.gov for CHIS data reporting and compares itwith the same data in corresponding published articles. bit.ly/41boTyz